Showing results (21-30 of 258) with videos related to

Sort By:
Pageof 26
Infection|January 1, 1995
Prevention of Pneumocystis carinii pneumonia and of cerebral toxoplasmosis by roxithromycin in HIV-infected patientsJ Durant, F Hazime, M Carles, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|August 3, 2006
Antimicrobial resistance of nasopharyngeal pneumococci from children from day-care centres and orphanages in Russia: results of a unique prospective multicentre studyL S Stratchounski, R S Kozlov, P C Appelbaum, et al.
The Journal of Antimicrobial Chemotherapy|October 1, 1983
Effect of clindamycin on growth and haemolysin production by Escherichia coliN M Boe, E P Dellinger, B H Minshew
The Journal of Antimicrobial Chemotherapy|December 1, 1987
Treatment failures of cefotaxime and latamoxef in meningitis caused by Enterobacter and Serratia sppR H Eng, C E Cherubin, J C Pechere, et al.
Antimicrobial Agents and Chemotherapy|January 30, 1999
In vivo emergence of multidrug-resistant mutants of Pseudomonas aeruginosa overexpressing the active efflux system MexA-MexB-OprMI Ziha-Zarifi, C Llanes, T Köhler, et al.
Annals of Surgery|April 1, 1980
Determinants of adverse reaction following postoperative T-tube cholangiogramE P Dellinger, G Kirshenbaum, M Weinstein, et al.
Infection and Immunity|April 1, 1992
Hemolysin-producing Listeria monocytogenes affects the immune response to T-cell-dependent and T-cell-independent antigensC M Hage-Chahine, G Del Giudice, P H Lambert, et al.
Journal of Bacteriology|August 22, 2001
Overexpression of the MexEF-OprN multidrug efflux system affects cell-to-cell signaling in Pseudomonas aeruginosaT Köhler, C van Delden, L K Curty, et al.
Antimicrobial Agents and Chemotherapy|November 26, 1997
Differential selection of multidrug efflux systems by quinolones in Pseudomonas aeruginosaT Köhler, M Michea-Hamzehpour, P Plesiat, et al.
International Journal of Antimicrobial Agents|November 3, 2004
Community-acquired pneumonia: new management strategies for evolving pathogens and antimicrobial susceptibilitiesK P Klugman, D E Low, J Metlay, et al.
Pageof 26